| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.6 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |